!

COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Baylor College of Medicine

Dr. Cheryl Lyn Walker

Early environmental exposure impacts liver epigenome

Graciela Gutierrez

713-798-4710

Houston, TX -
Content

You have often heard “You are what you eat,” but according to research from Baylor College of Medicine, the new phrase could be “You are what you are exposed to.” New research shows that, in animal models, the liver epigenome is permanently changed when exposed to certain chemicals in the environment early in life when the liver is developing, making the organism more vulnerable to diet-triggered metabolic dysfunction later in life. 

The findings, published in Nature Communications, show how early life chemical exposure actually reprograms the liver epigenome, aging it more rapidly.

“In our study, we found that even brief exposure to certain chemicals while the liver is developing prematurely aged the liver epigenome. Exposure to these endocrine-disrupting chemicals (EDCs) caused the young liver to acquire an adult epigenomic signature,” said Dr. Cheryl Walker, professor and director of the Center for Precision Environmental Health at Baylor and lead author on the study. “However, this premature aging of the epigenome did not have an effect on health until later in life and after exposure to a high-fat diet.”

The epigenome is sometimes referred to as the “software” or “operating system” of the genome. It is comprised of small chemical modifications to DNA and the proteins that make up our chromosomes, and controls the activity of all the genes within the genome. During early life, as our organs develop, the epigenome guides and changes along with normal developmental milestones. Exposure to an EDC during this process can cause widespread reprogramming of this “software,” and this reprogramming persists for the life of the individual. Depending on the organ, the window of vulnerability for this reprogramming may be anytime from development in the womb to childhood and adolescence, depending on how long normal development lasts. 

“In a healthy liver we see the epigemone go through a normal aging process. In our study, after exposure to an EDC, we were able to see this process accelerated. So a 6-day old rat had the same epigenome we would normally see in an adult rat,” said Walker, who also is the Alkek Presidential Chair in Environmental Health at Baylor. “The effect of this change on metabolic function wasn’t immediate; instead, it was like a ticking time bomb, which was only ignited when we switched the animals to a Western-style diet, high in fat, sugar and cholesterol.”

Rats that were exposed early to EDC and later to a Western-style diet were found to be more susceptible to metabolic dysfunction than those that had the same EDC exposure, but were kept on a healthy diet. Those that remained on a healthy diet, despite the fact their epigenome had been reprogrammed, did not show the same changes in expression of genes that control metabolism, or accumulation of lipids in their serum, seen in rats on the high fat, sugar and cholesterol diet.

“This study shows us how environmental exposures affect our health, and disease susceptibility, both early and later in life,” Walker said. “It also shows us that some people may be more adversely affected by a high-fat diet as adults than others due to environmental exposures they experienced earlier in their life.”

Featured as the June paper of the month by the National Institute of Environmental Health Sciences (NIEHS), this work was supported as part of the NIEHS multi-phased Toxicant Exposures and Responses by Genomic and Epigenomic Regulators of Transcription (TaRGET) Program.  While these findings are only in lab models at this time, researchers hope this and similar studies being conducted by the TARGET II Consortium can lead the way to identifying biomarkers to help better predict who is at risk for metabolic dysfunction such as fatty liver disease, diabetes or heart disease, and allow for more precise and early interventions.  

Others who contributed to the work include Lindsey S.Treviño, Jianrong Dong, Ahkilesh Kaushal, Tiffany A.Katz, Rahul Kumar Jangid, Matthew J.Robertson, Sandra L.Grimm, Chandra Shekar R. Ambati, Vasanta Putluri, Aaron R.Cox, Kang Ho Kim, Thaddeus D.May, Morgan R.Gallo, David D. Moore, Sean M. Hartig, Charles E.Foulds, Nagireddy Putluri, Cristian Coarfa. For affiliation please see the full publication in Nature Communications.

This work was supported in part by NIH grants U01ES026719, 1P30ES030285, andR01ES023206 to CLW, American Diabetes Association grant #1-18-IBS-105 and NIH grant R01DK114356 to S.M.H., and a sub-award from NIH grant U24DK097748 to C.E.F. Lipidomics and metabolomics sample processing and analysis were conducted by the Metabolomics Core at Baylor College of Medicine, supported by CPRIT Proteomics and Metabolomics Core Facility funding (RP170005), the NIH (P30 CA125123), and the Dan L Duncan Cancer Center at Baylor College of Medicine. 

Back to topback-to-top